| Literature DB >> 30789934 |
Anette Lampert1,2, Thomas Bruckner3, Walter E Haefeli1,2, Hanna M Seidling1,2.
Abstract
BACKGROUND: Eye-drop administration errors occur in the majority of patients and increase the risk for treatment failure or systemic adverse events. While lacking knowledge is the principal error cause, most patients overestimate their skills and are unaware of often substantial knowledge gaps. Therefore, the impact of including motivational patient education on long-term eye-drop administration skills of patients was investigated.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30789934 PMCID: PMC6383939 DOI: 10.1371/journal.pone.0212007
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinically relevant steps in the eye-drop administration process.
| Administration steps | Clinical relevance of incorrect execution | Principal cause of error |
|---|---|---|
| Hand washing | Manufacturer recommendation | Lacking knowledge |
| Instillation of a single drop | Systemic adverse events resulting from instillation of multiple drops and absorption through the lacrimal drainage system[ | Lacking skills |
| Instillation into the conjunctival sac | The drop misses the eye resulting in local side effects and waste of eye-drops, which increases treatment costs[ | Lacking skills |
| Eyelid closure for approximately one minute | Systemic adverse events because eyelid closure is omitted and ocular drugs become systemically available through the lacrimal drainage system[ | Lacking knowledge |
| Concomitant nasolacrimal occlusion | Systemic adverse events because nasolacrimal duct is not occluded and ocular drugs become systemically available through the lacrimal drainage system[ | Lacking knowledge |
| Avoid touching the dropper tip | Trauma, infection, ulceration, and visual loss resulting from contamination of the bottle tip by touching the ocular surface or eyelid[ | Lacking skills |
*Mentioning this step was sufficient for rating as correct.
Fig 1Flow diagram of the study.
Demographic data of study participants invited to follow-up visits.
| Intervention (N = 46) | Control (N = 45) | p-value | |
|---|---|---|---|
| Female sex N (%) | 29 (63 %) | 25 (56 %) | 0.31 |
| Age (mean ± SD) | 61.3 ± 15.4 years | 60.5 ± 16.7 years | 0.96° |
| Native language N (%) | 1 | ||
| German | 42 (91 %) | 41 (91 %) | |
| other | 4 (9 %) | 4 (9 %) | |
| Number of regularly administered drugs N (median, IQR) | 2 (1–4) | 3 (1–5) | 0.55 |
| Number of patients who used eye-drops for | 0.98 | ||
| less than one year N (%) | 22 (48 %) | 19 (42 %) | |
| more than one year N (%) | 24 (52 %) | 26 (58 %) | |
| Previous education on | 6 (13 %) | 12 (27 %) | 0.01 |
IQR = Interquartile range, SD = standard deviation
*p-values were calculated using a chi-squared test.
°p-values were calculated using a Mann-Whitney U test.
Fig 2Patients who correctly administered their eye-drops before and after counseling.
Correctly performed eye-drop administration at baseline of all patients (black), intervention group (grey), and control group (white) who regularly used eye-drops (A). Correctly performed eye-drop administration after counseling of all patients (black), intervention group (grey), and control group (white) who regularly administer eye-drops (B). Seven patients in the intervention group and one patient in the control group correctly administered eye-drops at baseline and, thus, received no counseling (C). Correctly performed eye-drop administration after counseling of all patients (black), intervention group (grey), and control group (white) using eye-drops for the first time (bottom). The eye-drop administration process comprised six steps: 1 = hand washing, 2 = instilling a single drop, 3 = instillation into the conjunctival sac, 4 = eyelid closure for approximately one minute, 5 = concomitant nasolacrimal occlusion, and 6 = dropper tip was not touched. *significant compared to baseline (p ≤ 0.001).
Fig 3Patients who correctly administered their eye-drops at baseline and follow-ups.
Number of patients who correctly administered eye-drops prior to counseling at baseline, 1-month follow-up, and 6-month follow-up in relation to the total number of patients (black), all patients in the intervention group (grey), or in the control group (white) who were assessed for eye-drop administration errors. *significant compared to baseline (p ≤ 0.001).